Sign up to save your podcasts
Or
Share BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BTK Inhibitors in Multiple Sclerosis Treatment - Part 1
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
View all episodes
By American Academy of Neurology
4.8
129129 ratings
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Jiwon Oh discuss how Bruton Tyrosine Kinase (BTK) Inhibitors work and how they vary from other disease-modifying therapies.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2415985
https://www.nejm.org/doi/full/10.1056/NEJMoa2415988
More shows like Neurology Minute
View all
JAMA Clinical Reviews
497 Listeners
Neurology® Podcast
294 Listeners
Practical Neurology Podcast
51 Listeners
Mayo Clinic Talks
288 Listeners
The Curbsiders Internal Medicine Podcast
3,337 Listeners
Emergency Medical Minute
260 Listeners
JAMA Neurology Author Interviews
13 Listeners
Neurology Today in 5
22 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
513 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
366 Listeners
Short Wave
6,357 Listeners
Neurology Exam Prep Podcast
181 Listeners
The Curious Clinicians
370 Listeners
Continuum Audio
79 Listeners